Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CLLS — Cellectis S.A.

CIK 1446194 BALA CYNWYD, PA

Position in CLLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$209,035
-$44,692 QoQ
Shares Held
65,942
+25.8% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in CLLS Over Time

Shares Held

Position Value (USD)

Derivatives in CLLS

reported options exposure · as of Sep 30, 2025
CallValue
$150,195
CallShares
52,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,176,415,994 across 355 Biotechnology names. CLLS ranks #289 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLLS

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $209,035 65,942
2025-12-31 $253,727 52,423
2025-09-30 $153,515 53,865
2025-09-30 $150,195 52,700
2025-06-30 $52,510 34,433
2024-09-30 $27,581 13,010
2024-06-30 $31,416 16,800
2024-03-31 $81,885 30,900
2024-03-31 $73,285 27,655
2023-12-31 $60,133 19,524
2022-12-31 $121,982 58,087
2022-06-30 $28,583 10,100
2022-03-31 $65,376 14,400
2021-12-31 $130,732 16,100
2021-12-31 $138,852 17,100
2021-12-31 $180,970 22,287
2021-09-30 $252,200 20,000
2021-09-30 $140,185 11,117
2021-09-30 $268,593 21,300
2021-06-30 $496,587 32,100
2021-06-30 $224,315 14,500
2021-06-30 $350,797 22,676
2021-03-31 $813,917 40,273
2021-03-31 $899,345 44,500
2021-03-31 $959,975 47,500
2020-12-31 $730,620 27,000
2020-12-31 $1,234,504 45,621
2020-12-31 $1,631,718 60,300
2020-09-30 $373,700 20,200
2020-03-31 $237,360 25,800